Molecular diagnostics for perioperative microbial identification in periprosthetic joint infection: A scoping review

Pier Francesco Indelli1,2, Trifon Totlis1,3, Bruno Lovreković2,4

  • 1European Society of Sports Traumatology, Knee Surgery Arthroscopy (ESSKA) - European Knee Associates (EKA) Board Luxembourg Luxembourg.

Abstract

Insights

Molecular diagnostics offer a valuable alternative to traditional cultures for identifying causative agents in periprosthetic joint infections (PJI). Integrating these nucleic acid-based strategies with standard cultures can improve PJI treatment decisions.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Periprosthetic joint infections (PJI) are severe complications following joint replacement surgery.
  • Traditional culture methods often fail to accurately identify the causative microorganisms in PJI.
  • Molecular diagnostics utilize DNA/RNA analysis to detect microbial species, overcoming culture limitations.

Purpose of the Study:

  • To conduct a scoping review on molecular diagnostic techniques for PJI.
  • To evaluate the role of molecular diagnostics in surgical treatment decision-making for PJI.
  • To develop a flowchart for PJI management based on molecular diagnostics.

Main Methods:

  • A scoping review of the literature was performed.
  • Searches were conducted in PubMed, Embase, Scopus, and the Cochrane Library.
  • Included studies focused on molecular diagnostic methods for perioperative microbial infections in hip or knee arthroplasty patients.

Main Results:

  • Seventy-five articles were included, categorized into PCR (18), Next-Generation Sequencing (40), comparative studies (7), and general reviews (10).
  • Molecular diagnostics are increasingly valuable for PJI treatment decisions.
  • Next-Generation Sequencing was the most frequently studied molecular method.

Conclusions:

  • Molecular diagnostics are becoming essential tools in managing PJI.
  • While culture remains the gold standard, nucleic acid-based strategies can complement it.
  • Integration of molecular diagnostics with standard cultures is feasible and recommended for PJI management in 2025.